TERRI KLICK: Open Payments
NPI 1558649905 · MANGHAM, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 17 payments from 9 companies in 2025. Trend: 2023 $204 · 2024 $708 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $137 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $83 |
| ABBVIE INC. | 4 | $76 |
| Alpha Cognition USA, Inc. | 1 | $72 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: CAPLYTA, JARDIANCE, Zunveyl, VRAYLAR, REXULTI, AUSTEDO XR, MOUNJARO, UBRELVY.
Industry payments across LA — which companies pay providers there.
